AUTOIMMUNE OPTIC NEUROPATHY (AON) PROFILE AT OPHTHALMOLOGY OUTPATIENT CLINIC OF A TERTIARY HOSPITAL IN SURABAYA, INDONESIA
Downloads
Highlights
- Autoimmune optic neuropathy (AON) is one of the diseases that involve the central nervous system (CNS) and can result in disability if not treated quickly and appropriately.
- The autoimmune optic neuropathy (AON) patient's profile, including disease etiology and therapy, is essential to minimize the incidence of AON.
Abstract
Background: Autoimmune optic neuropathy (AON) is a kind of optic neuritis that causes progressive and severe vision loss. The presence of an autoimmune disease usually characterizes the diagnosis of this disease. Several autoimmune processes that can cause AON are Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Immunoglobulin (MOG-IgG), and other disorders, specifically systemic autoimmune disease, such as Systemic Lupus Erythematous (SLE), Sjogren's Syndrome, and Sarcoidosis. Risk factors for AON involve young adults and women. Most of the patients received therapy according to the ONTT protocol and underwent outpatient treatment with oral methylprednisolone or prednisone. Objective: The study aimed to obtain the autoimmune optic neuropathy (AON) profile in patients at the Ophthalmology Outpatient Installation of Dr. Soetomo General Academic Hospital Surabaya, Indonesia, in the 2017-2022 Period. Material and Method: This retrospective descriptive study used medical records; 70 subjects were included. Result: Most subjects suffered from SLE (55.7%) as the cause of AON and received therapy according to the ONTT protocol, namely oral methylprednisolone or prednisone (67.1%) with outpatient therapy. Some patients were given other therapies (25.7%), such as mecobalamin and other B complex vitamins. Conclusion: AON is an uncommon condition. However, if not treated promptly and effectively, it can result in handicaps. This study may serve as a reference for future relevant research and as an attempt to prevent the disease.
Abel, A., McClelland, C., Lee, M. S. 2019. Critical review: Typical and atypical optic neuritis. Survey of Ophthalmology, 64(6): 770–779. doi 10.1016/j.survophthal.2019.06.001.
Anand, O. P. 2019. Vitamin B12 deficiency induced optic neuropathy. Delhi Journal of Ophthalmology, 29(4). doi: 10.7869/djo.467.
Bandoli, L., Moura, F. 2022. Autoimmune optic neuropathy as the differential diagnosis of neuromyelitis optica spectrum disorders. Arquivos Brasileiros de Oftalmologia, 85(5). doi: 10.5935/0004-2749.20220064.
Bennett, J. L. 2019. Optic neuritis. CONTINUUM: Lifelong Learning in Neurology, 25(5): 1236–1264. doi: 10.1212/CON.0000000000000768.
Chen, J.J., Pittock, S.J., Flanagan, E.P., et al. 2020. Optic neuritis in the era of biomarkers. Survey of Ophthalmology, 65(1): 12–17. doi:10.1016/j.survophthal.2019.08.001.
Dahanayake, P., Dassanayake, T., Pathirage, M., et al. 2021. The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study. BMC Ophthalmology, 21(1): 324. doi: 10.1186/s12886-021-02086-z.
Dammacco, R. 2018. Systemic lupus erythematosus and ocular involvement: an overview. Clinical and Experimental Medicine, 18(2): 135–149. doi: 10.1007/s10238-017-0479-9.
Durmaz, Z. H., Ayan, D., Demir, A. D., et al. 2020. Vitamin D levels in multiple sclerosis. MNJ (Malang Neurology Journal), 6(1): 28–31. doi: 10.21776/ub.mnj.2020.006.01.6.
Fatima, S., Triningrat, A. A., Kusumadjaja, I. M. A., et al. 2021. Karakteristik pasien optic neuritis di Rumah Sakit Umum Pusat (RSUP) Sanglah periode 1 Januari-31 Desember 2018. E-Jurnal Medika Udayana, 10(7): 68. doi: 10.24843/MU.2021.V10.i7.P13.
Frohman, L., DellaTorre, K., Turbin, R., et al. 2009. Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy. British Journal of Ophthalmology, 93(12): 1660–1666. doi: 10.1136/bjo.2009.159350.
García Ortega, A., Montañez Campos, F.J., Muñoz, S., et al. 2020. Autoimmune and demyelinating optic neuritis. Archivos de la Sociedad Española de Oftalmología (English Edition), 95(8): 386–395. doi: 10.1016/j.oftale.2020.05.011.
Glover, K., Mishra, D., Singh, T. R. R. 2021. Epidemiology of ocular manifestations in autoimmune disease. Frontiers in Immunology, 12. doi: 10.3389/fimmu.2021.744396.
Lassie, N., Hartono, H. 2020. Visual outcome after oral versus intravenous methylpredisolone therapy for bilateral optic neuritis in adults. Health & Medical Journal, 2(1): 06–10. doi: 10.33854/heme.v2i1.260.
Morrow, M. J., Ko, M. W. 2017. Should oral corticosteroids be used to treat demyelinating optic neuritis?. Journal of Neuro-Ophthalmology, 37(4): 444–450. doi: 10.1097/WNO.0000000000000555.
Morrow, S. A., Fraser, J. A., Day, C., et al. 2018. Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids. JAMA Neurology, 75(6): 690. doi: 10.1001/jamaneurol.2018.0024.
Paramita, P., Louisa, M. 2017. Berbagai manfaat vitamin D. Cermin Dunia Kedokteran, 44(10): 399703. doi:10.55175/cdk.v44i10.720.
Petzold, A., Plant, G. T. 2014. Diagnosis and classification of autoimmune optic neuropathy. Autoimmunity Reviews, 13(4–5): 539–545. doi: 10.1016/j.autrev.2014.01.009.
Phuljhele, S., Kedar, S., Saxena, R. 2021. Approach to optic neuritis: An update. Indian Journal of Ophthalmology, 69(9): 2266. doi: 10.4103/ijo.IJO_3415_20.
Shoughy, S. S., Tabbara, K. F. 2016. Ocular findings in systemic lupus erythematosus. Saudi Journal of Ophthalmology, 30(2): 117–121. doi: 10.1016/j.sjopt.2016.02.001.
Tajfirouz, D. A., Bhatti, M. T., Chen, J. J. 2019. Clinical characteristics and treatment of MOG-IgG–associated optic neuritis. Current Neurology and Neuroscience Reports, 19(12): 100. doi: 10.1007/s11910-019-1014-z.
Vanikieti, K., Janyaprasert, P., Lueangram, S., et al. 2020. Etiologies of acute optic neuritis in Thailand: An observational study of 171 patients. Clinical Ophthalmology, 14: 2935–2942. doi: 10.2147/OPTH.S271820.
Wilhelm, H., Schabet, M. 2015. The diagnosis and treatment of optic neuritis. Deutsches í„rzteblatt International. doi: 10.3238/arztebl.2015.0616.
Zahid, S., Iqbal, M. 2019. Systemic lupus erythematosus presenting as optic neuropathy: A case report. Cureus, 11(6): e4806. doi: 10.7759/cureus.4806.
Copyright (c) 2024 Devanty Dwi Santosa, Lukisiari Agustini, Artaria Tjempakasari
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author(s) to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International License (CC-BY).
